Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course HIPEC in Ovarian Cancer
NCT02249013Phase 2Completed
- Sponsor
- IMIP
- Start
- Feb 2015
- Primary completion
- Feb 2021
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of cisplatin, doxorubicin in ovarian cancer, sponsored by IMIP. Started Feb 2015; status: completed.
02
Drugs
cisplatindoxorubicin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02249013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02249013.